Cites del registre

Cita APA (7th ed.)
Langlois, J., Lange, S., Ebeling, M., Macnair, W., Schmucki, R., Li, C., . . . Keaney, J. (2024). Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways. BMC.
Cita Chicago (17th ed.)
Langlois, Julie, et al. Fenebrutinib, a Bruton’s Tyrosine Kinase Inhibitor, Blocks Distinct Human Microglial Signaling Pathways. BMC, 2024.
Cita MLA (9th ed.)
Langlois, Julie, et al. Fenebrutinib, a Bruton’s Tyrosine Kinase Inhibitor, Blocks Distinct Human Microglial Signaling Pathways. BMC, 2024.
Atenció: Aquestes cites poden no estar 100% correctes.